Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    12699447 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Testosterone Replacement in Metabolic Syndrome and Inflammation
Conditions: Hypogonadism;   Metabolic Syndrome;   Obesity;   Erectile Dysfunction
Interventions: Drug: Testosterone;   Drug: Placebo
2 Completed Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors
Conditions: Hypogonadism;   Erectile Dysfunction
Intervention: Drug: Fispemifene (once daily for 8 weeks)
3 Withdrawn Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors
Condition: Impotence
Intervention: Drug: Fluvastatin-sodium

Study has passed its completion date and status has not been verified in more than two years.